Predicting disease progression in patients with viable: Tumor at post-chemotherapy RPLND

被引:0
|
作者
Spiess, Philippe E.
Brown, Gordon A.
Tannir, Nizar M.
Tu, Shi-Ming
Liu, Ping
Kamat, Ashish M.
Wood, Christopher G.
Evans, James G.
Pisters, Louis L.
机构
来源
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词
D O I
10.1016/S0022-5347(18)31074-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:278 / 278
页数:1
相关论文
共 50 条
  • [21] Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND)
    Nini, Alessandro
    Boschheidgen, Matthias
    Hiester, Andreas
    Winter, Christian
    Antoch, Gerald
    Schimmoller, Lars
    Albers, Peter
    WORLD JOURNAL OF UROLOGY, 2022, 40 (02) : 349 - 354
  • [22] POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) FOR SEMINOMA: IS SURGERY EFFECTIVE?
    Tachibana, Isamu
    Alabd, Andre
    Whaley, Rumeal
    Mcfadden, Jacob
    Piroozi, Alex
    Kern, Sean
    Adra, Nabil
    Foster, Richard
    Einhorn, Lawrence
    Cary, Clint
    Masterson, Timothy
    JOURNAL OF UROLOGY, 2023, 209 : E687 - E688
  • [23] Characterization of the ovarian tumor transcriptome and microenvironment in pre and post-chemotherapy treated patients
    Jordan, Kimberly R.
    Slansky, Jill
    Minic, Angela
    Richer, Jennifer K.
    Costello, James C.
    Clauset, Aaron J.
    Kumar, Rajendra T.
    Behbakht, Kian
    Sikora, Matthew J.
    Bitler, Benjamin G.
    CANCER RESEARCH, 2020, 80 (16)
  • [24] Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study
    Xiaoming Fei
    Fang Lei
    Haifeng Zhang
    Hua Lu
    Yan Zhu
    Yu Tang
    Supportive Care in Cancer, 2016, 24 : 2727 - 2733
  • [25] Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study
    Fei, Xiaoming
    Lei, Fang
    Zhang, Haifeng
    Lu, Hua
    Zhu, Yan
    Tang, Yu
    SUPPORTIVE CARE IN CANCER, 2016, 24 (06) : 2727 - 2733
  • [26] Can tumor-to-liver (T/L) ratio predict progression free survival in patients with post-chemotherapy seminoma residual
    Ghosh, S.
    Agrawal, A.
    Rangarajan, V.
    Choudhury, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S149 - S149
  • [27] Reproduction post-chemotherapy in young cancer patients
    Meirow, D
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 169 (1-2) : 123 - 131
  • [28] WILMS-TUMOR - PRE-CHEMOTHERAPY AND POST-CHEMOTHERAPY CT APPEARANCES
    NG, YY
    HALLCRAGGS, MA
    DICKSMIREAUX, C
    PRITCHARD, J
    CLINICAL RADIOLOGY, 1991, 43 (04) : 255 - 259
  • [29] POST-CHEMOTHERAPY STAGING LAPAROTOMY IN HODGKINS-DISEASE
    BARR, LC
    GLEES, JP
    MCELWAIN, TJ
    PECKHAM, MJ
    GAZET, JC
    BRITISH JOURNAL OF CANCER, 1982, 45 (02) : 174 - 178
  • [30] THE PROGRESSION OF BONE MINERAL DENSITY ABNORMALITIES POST-CHEMOTHERAPY IN CHILDREN WITH ALL
    Vitanza, Nick
    Parker, Robert
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 819 - 820